Schedule 13G ownership disclosure
PYXIS ONCOLOGY INC
Common Stock, par value $0.001 per share · CUSIP: 747324101
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Laurion Capital Management LP
Shares: 4,300,888 · Class: 5.16%
- Benjamin Alexander Smith
Shares: 4,300,888 · Class: 5.16%
- Janaka Sheehan Maduraperuma
Shares: 4,300,888 · Class: 5.16%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001390202-26-000019
- Form type
- SCHEDULE 13G/A
- Filer
- Pyxis Oncology, Inc.
- CIK
- CIK 1782223
- Filed
- Nov 03, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership